Drug-induced pulmonary pneumonitis and fibrosis — VA Rating Criteria (38 CFR DC 6829)
The VA rates Drug-induced pulmonary pneumonitis and fibrosis under 38 CFR 38 CFR § 4.97, Diagnostic Code 6829, from 100% to 100% based on the frequency and functional severity of symptoms. The maximum 100% rating requires Active infection with systemic symptoms such as fever, night sweats, weight loss, or hemoptysis. Related conditions in the Respiratory body system share this rating framework.
What are the VA rating criteria for Drug-induced pulmonary pneumonitis and fibrosis?
Active infection with systemic symptoms such as fever, night sweats, weight loss, or hemoptysis
“Active infection with systemic symptoms such as fever, night sweats, weight loss, or hemoptysis”
How does the VA rate Respiratory conditions?
Common Questions About Drug-induced pulmonary pneumonitis and fibrosis VA Ratings
What is the VA disability rating for Drug-induced pulmonary pneumonitis and fibrosis?
The VA rates Drug-induced pulmonary pneumonitis and fibrosis under Diagnostic Code 6829 at the following tiers: 100%. The minimum 100% rating requires: Active infection with systemic symptoms such as fever, night sweats, weight loss, or hemoptysis. The maximum 100% rating requires: Active infection with systemic symptoms such as fever, night sweats, weight loss, or hemoptysis.
What is Diagnostic Code 6829?
Diagnostic Code 6829 is the VA rating identifier for Drug-induced pulmonary pneumonitis and fibrosis within 38 CFR 38 CFR § 4.97. It defines the specific symptom criteria and percentage thresholds a VA adjudicator uses to assign a disability rating. The diagnostic code is listed on a veteran's rating decision letter.
What is the highest rating for Drug-induced pulmonary pneumonitis and fibrosis?
The highest schedular rating for Drug-induced pulmonary pneumonitis and fibrosis under DC 6829 is 100%. This tier requires: Active infection with systemic symptoms such as fever, night sweats, weight loss, or hemoptysis. Veterans who cannot secure substantially gainful employment due to Drug-induced pulmonary pneumonitis and fibrosis alone or in combination with other service-connected conditions may also qualify for TDIU at the 100% compensation rate under 38 CFR § 4.16.
What 38 CFR section governs Drug-induced pulmonary pneumonitis and fibrosis ratings?
Drug-induced pulmonary pneumonitis and fibrosis is rated under 38 CFR 38 CFR § 4.97, Diagnostic Code 6829. This section is part of the Schedule for Rating Disabilities (38 CFR Part 4) and can be read in full at the eCFR website.
Which conditions are commonly secondary to Drug-induced pulmonary pneumonitis and fibrosis?
Secondary conditions caused or aggravated by Drug-induced pulmonary pneumonitis and fibrosis may be ratable under 38 CFR § 3.310. Veterans should work with a VSO or accredited claims agent to document the medical relationship.
What evidence do I need to establish service connection for Drug-induced pulmonary pneumonitis and fibrosis?
Service connection for Drug-induced pulmonary pneumonitis and fibrosis requires three elements: (1) a current diagnosis of the condition, (2) an in-service event, injury, or disease that may have caused or aggravated it, and (3) a medical nexus connecting the current diagnosis to that in-service event. A nexus letter from a treating physician or independent medical examiner is the most reliable nexus evidence. C&P exam findings can also establish nexus if adequately documented.
Get a Personalized Rating Analysis
VeteranHQ evaluates your symptoms against the exact 38 CFR criteria, identifies secondary conditions, and shows what evidence you need to support a higher rating.
Discover Your Benefits